Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

180 Life Sciences Corp WT (ATNFW)

180 Life Sciences Corp WT (ATNFW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,940 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ATNFW with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/20/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0071 +40.85%
on 07/17/24
0.0222 -54.95%
on 07/09/24
+0.0009 (+9.89%)
since 06/26/24
3-Month
0.0054 +85.19%
on 06/10/24
0.0300 -66.67%
on 06/11/24
unch (unch)
since 04/26/24
52-Week
0.0030 +233.33%
on 03/13/24
0.0300 -66.67%
on 06/11/24
+0.0007 (+7.53%)
since 07/26/23

Most Recent Stories

More News
180 Life Sciences Corp. Announces Closing of $11.7 Million Private Placement

MENLO PARK, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase...

ATNFW : 0.0100 (+1.01%)
ATNF : 2.30 (unch)
180 Life Sciences Corp. Announces $11.7 Million Private Placement

MENLO PARK, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase...

ATNFW : 0.0100 (+1.01%)
ATNF : 2.30 (unch)
180 Life Sciences Corp. to Present at the H.C. Wainwright Bioconnect 2021 Conference

MENLO PARK, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in...

ATNF : 2.30 (unch)
ATNFW : 0.0100 (+1.01%)
180 Life Sciences Corp. to Present at the 13th Annual LD Micro Main Event Conference on Tuesday, December 15th at 1:40 PM EST

MENLO PARK, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) ("180 Life Sciences" or "the Company"), a clinical-stage biotechnology company with its lead indication...

ATNF : 2.30 (unch)
ATNFW : 0.0100 (+1.01%)
180 Life Sciences Corp. to Ring Nasdaq Opening Bell on November 27, 2020

MENLO PARK, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in...

ATNF : 2.30 (unch)
ATNFW : 0.0100 (+1.01%)
180 Life Sciences Corp. Continues to Expand Intellectual Property Portfolio With Additional Patent Grants

MENLO PARK, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused...

ATNF : 2.30 (unch)
ATNFW : 0.0100 (+1.01%)
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders

MENLO PARK, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused...

ATNF : 2.30 (unch)
ATNFW : 0.0100 (+1.01%)
180 Life Sciences Announces Completion of Transaction with KBLM Merger Corp IV

Company Now Publicly Traded on Nasdaq Under the ticker ATNF

ATNF : 2.30 (unch)
ATNFW : 0.0100 (+1.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar